[Long-term therapy of gout and hyperuricemia].
D000493:Allopurinol / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology; D001796:Blood Protein Disorders / Q000209:etiology; D002951:Citrates / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000209:etiology; D004035:Diet Therapy; D006073:Gout / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D006973:Hypertension / Q000209:etiology; D007669:Kidney Calculi / Q000209:etiology; D007674:Kidney Diseases / Q000209:etiology; D010653:Phenylbutazone / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D013997:Time Factors; D014511:Uremia / Q000209:etiology; D014527:Uric Acid / Q000097:blood
D002951:Citrates; D014527:Uric Acid; D000493:Allopurinol; D010653:Phenylbutazone; D003078:Colchicine
Probleme der Langzeitbehandlung der Hyperurikämie und der Gicht.